To date, a number of mechanistic pathways have been identified to explain the pathogenic activities of TDP-43 and FUS in ALS and FTLD, including disruption of mitochondrial function, disturbance of proteostasis, pro-inflammatory responses, and oxidative stress [55]. Here, TARDBP is linked to amyotrophic lateral sclerosis.